Eli Lilly launched a new form of its weight-loss drug Zepbound on Tuesday for about half the usual monthly list price, in an effort to reach millions of patients who don’t have coverage for the popular injection, such as those with Medicare. The move is also intended to increase supply of Zepbound in the United […]